Accretion Pharmaceuticals (NSE:ACCPL) FCF Margin %: -10.01% (As of Mar. 2026)


NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
18 GF Score
Price ₹149.15
! 5 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals FCF Margin %?

Accretion Pharmaceuticals NSE:ACCPL -1.81% 18 FCF Margin % is -10.01% as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 958 Drug Manufacturers companies, Accretion Pharmaceuticals ranks worse than 84.03% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Accretion Pharmaceuticals's Free Cash Flow for the six months ended in Mar. 2026 was ₹-45.9 Mil. Accretion Pharmaceuticals's Revenue for the six months ended in Mar. 2026 was ₹458.9 Mil. Therefore, Accretion Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -10.01%.

As of today, Accretion Pharmaceuticals's current FCF Yield % is -13.96%.

The historical rank and industry rank for Accretion Pharmaceuticals's FCF Margin % or its related term are showing as below:

NSE:ACCPL' s FCF Margin % Range Over the Past 10 Years
Min: -25.83   Med: -2.92   Max: 8.49
Current: -25.83

During the past 5 years, the highest FCF Margin % of Accretion Pharmaceuticals was 8.49%. The lowest was -25.83%. And the median was -2.92%.

NSE:ACCPL's FCF Margin % is ranked worse than
84.03% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs NSE:ACCPL: -25.83

Accretion Pharmaceuticals FCF Margin % Related Terms

Accretion Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals FCF Margin % Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
8.49 -2.92 -4.26 7.21 -25.83

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -42.44 -10.01

NSE:ACCPL vs LLY, JNJ, ABBV: FCF Margin % Comparison

For the Drug Manufacturers - General subindustry, Accretion Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accretion Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accretion Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Accretion Pharmaceuticals's FCF Margin % falls into.


NSE:ACCPL
18GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Accretion Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-231.546/896.271
=-25.83 %

Accretion Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-45.939/458.909
=-10.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -10.01% mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a FCF Margin % of -10.01% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Accretion Pharmaceuticals and its competitors. According to the industry distribution chart, Accretion Pharmaceuticals ranks #805 out of 958 companies in the Drug Manufacturers industry, placing it in the top 84%.
Is Accretion Pharmaceuticals' FCF Margin % too high?
Accretion Pharmaceuticals' current FCF Margin % is -10.01%. Based on the distribution chart, Accretion Pharmaceuticals ranks #805 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Accretion Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Accretion Pharmaceuticals ranks #805 out of 958 companies for FCF Margin %. This places Accretion Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Accretion Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accretion Pharmaceuticals's current FCF Margin % is -10.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current FCF Margin % of -10.01%. The current FCF Margin % is -10.01%. Accretion Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current FCF Margin % is -10.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
18GF Score

Get the complete analysis for NSE:ACCPL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹149.15
Price